Bringing together treatment and referral advice from existing guidelines, this text aims to improve access to services and recognition of common mental health disorders in adults and provide advice on the principles that need to be adopted to develop appropriate referral and local care pathways.

This text sets out clear recommendations for healthcare staff (based on the best available evidence) on how to assess and manage adults and young people (aged 14+) who have both psychosis and a substance misuse problem, in order to integrate treatment for both conditions and thus improve their care.

Antisocial behaviour and conduct disorders are the most common reason for referral to child and adolescent mental health services and have a significant impact on the quality of life of children and young people and their parents and carers. Rates of other mental health problems (including antisocial personality disorder) are considerably increased for adults who had a conduct disorder in childhood. This new NICE guideline seeks to address these problems by offering advice on prevention strategies and a range of psychosocial interventions.It reviews the evidence across the care pathway, encompassing access to and delivery of services, experience of care, selective prevention interventions, case identification and assessment, psychological and psychosocial indicated prevention and treatment interventions, and pharmacological and physical interventions.Readership: Intended for healthcare professionals in CAMHS, but this will also be useful to professionals in primary care (as there is much emphasis on recognition).

These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.

Sets out clear recommendations for healthcare staff (based on the best available evidence) on how to diagnose and manage children and young people who have depression, in order to significantly improve their treatment and care.

Annotation This title examines the evidence, and gives recommendations, for improving service users' experience of mental health services in seven main areas.

This book presents the evidence base for the NICE guideline on the management of bipolar disorder in adults (including pregnant women and older adults), children and adolescents. It covers diagnosis and assessment in primary and secondary care, and pharmacological, psychological and psychosocial management. The guideline also contains a chapter on patient experience. An essential resource for all professionals involved in the treatment and management of bipolar disorder, this book is a milestone in the development of truly independent and transparent clinical guidance and an essential tool in improving the quality of mental healthcare in the UK. NICE Mental Health Guidelines These guidelines from the National Institute for Health and Clinical Excellence (NICE) set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions. The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. The accompanying free CD-ROM contains all the data used as evidence, including: Included and excluded studies. Profile tables that summarise both the quality of the evidence and the results of the evidence synthesis. All meta-analytical data, presented as forest plots. Detailed information about how to use and interpret forest plots.

This guideline has been developed to advise on the identification, treatment and management of obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD). Although distinct disorders, OCD and BDD share a number of common features and there is a high degree of similarity between the treatments for the two conditions. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, people with OCD, a carer and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high quality care for those with OCD and BDD while also emphasising the importance of the experience of care for people with OCD, BDD, and carers. This guideline addresses aspects of service provision, psychological and pharmacological approaches for those with OCD and BDD from the age of 8 upwards. Although the evidence base is rapidly expanding, there are a number of major gaps and future revisions of this guideline will incorporate new scientific evidence as it develops. The guideline makes a number of research recommendations specifically to address these gaps in the evidence base. In the meantime, we hope that the guideline will assist clinicians, people with these disorders and their carers by identifying the merits of particular treatment approaches where the evidence from research and clinical experience exists.

The guideline on dementia is the first of its kind to fully integrate the health and social aspects of care for people with dementia into a single volume. It has been jointly developed by NICE (the National Institute for Health and Clinical Excellence) and SCIE (the Social Care Institute for Excellence). There are an estimated 700,000 people with dementia in the UK and approximately 1 million people caring for them. The guideline sets out clear recommendations, based on the best available evidence, for health and social care staff on how to work with people with dementia and their carers to significantly improve their treatment and care. This publication brings together all of the evidence that led to the recommendations in the guideline. It provides an overview of the condition and covers detection, diagnosis and assessment, and the full range of treatment and care approaches for people with dementia including promoting independence, psychological and psychosocial interventions, pharmacological treatments and palliative care. Importantly, it also addresses support and interventions for carers of people with dementia.

This evidence-based clinical guideline endorsed by NICE (National Institute for Clinical Excellence) presents guidance on pharmacological, psychological and service-level interventions for schizophrenia.